Global Preclinical CRO Market Insights, Forecast to 2028

List of Tables

Market Analysis and Insights:

The global Preclinical CRO market size is projected to reach US$ 23,381 million by 2028, from US$ 13,017 million in 2021, at a CAGR of 8.27% during 2022-2028.

Fully considering the economic change by this health crisis, Bioanalysis and DMPK Studies accounting for 46.53% of the Preclinical CRO global market in 2021, is projected to value US$ 11,059 million by 2028, growing at a revised 8.60% CAGR in the post-COVID-19 period. While Pharmaceutical Companies segment is altered to an 8.06% CAGR throughout this forecast period.

China Preclinical CRO market size is valued at US$ 3,084 million in 2021, while the North America and Europe Preclinical CRO are US$ 5,966 million and US$ 2,124 million, severally. The proportion of the North America is 45.83% in 2021, while China and Europe are 23.69% and 16.32% respectively, and it is predicted that China proportion will reach 28.43% in 2028, trailing a CAGR of 10.69% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR 5.56%, 5.98%, and 8.21% respectively for the next 6-year period. As for the Europe Preclinical CRO landscape, Germany is projected to reach US$ 874 million by 2028 trailing a CAGR of 5.94% over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical CRO market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical CRO market.

Scope and Market Size:

Preclinical CRO market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company

Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON Plc
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology

Segment by Type

Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others

Segment by Application

Pharmaceutical Companies
Medical Device Companies
Other

By Region

North America
- United States
- Canada

Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia

Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe

Latin America
- Mexico
- Brazil
- Rest of Latin America

Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

1 Report Overview

1.1 Study Scope
1.2 Market Analysis by Type
- 1.2.1 Global Preclinical CRO Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
- 1.2.2 Bioanalysis and DMPK Studies
- 1.2.3 Toxicology Testing
- 1.2.4 Safety Pharmacology
- 1.2.5 Other
1.3 Market by Application
- 1.3.1 Global Preclinical CRO Market Share by Application: 2017 VS 2021 VS 2028
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Medical Device Companies
- 1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends

2.1 Global Preclinical CRO Market Perspective (2017-2028)
2.2 Preclinical CRO Growth Trends by Region
- 2.2.1 Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Preclinical CRO Historic Market Size by Region (2017-2022)
- 2.2.3 Preclinical CRO Forecasted Market Size by Region (2023-2028)
2.3 Preclinical CRO Market Dynamics
- 2.3.1 Preclinical CRO Industry Trends
- 2.3.2 Preclinical CRO Market Drivers
- 2.3.3 Preclinical CRO Market Challenges
- 2.3.4 Porter's Five Forces Analysis

3 Competition Landscape by Key Players

3.1 Global Top Preclinical CRO Players by Revenue
- 3.1.1 Global Top Preclinical CRO Players by Revenue (2019-2022)
- 3.1.2 Global Preclinical CRO Revenue Market Share by Players (2019-2022)
3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Preclinical CRO Revenue
3.4 Global Preclinical CRO Market Concentration Ratio
- 3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5)
- 3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2021
3.5 Preclinical CRO Key Players Head office and Area Served
3.6 Established Date of Preclinical CRO Players
3.7 Mergers & Acquisitions, Expansion Plans

4 Preclinical CRO Breakdown Data by Type

4.1 Global Preclinical CRO Historic Market Size by Type (2017-2022)
4.2 Global Preclinical CRO Forecasted Market Size by Type (2023-2028)

5 Preclinical CRO Breakdown Data by Application

5.1 Global Preclinical CRO Historic Market Size by Application (2017-2022)
5.2 Global Preclinical CRO Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Preclinical CRO Market Size (2017-2028)
6.2 North America Preclinical CRO Market Size by Type
- 6.2.1 North America Preclinical CRO Market Size by Type (2017-2022)
- 6.2.2 North America Preclinical CRO Market Size by Type (2023-2028)
- 6.2.3 North America Preclinical CRO Market Share by Type (2017-2028)
6.3 North America Preclinical CRO Market Size by Application
- 6.3.1 North America Preclinical CRO Market Size by Application (2017-2022)
- 6.3.2 North America Preclinical CRO Market Size by Application (2023-2028)
- 6.3.3 North America Preclinical CRO Market Share by Application (2017-2028)
6.4 North America Preclinical CRO Market Size by Country
- 6.4.1 North America Preclinical CRO Market Size by Country (2017-2022)
- 6.4.2 North America Preclinical CRO Market Share by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada

7 Europe

7.1 Europe Preclinical CRO Market Size (2017-2028)
7.2 Europe Preclinical CRO Market Size by Type
- 7.2.1 Europe Preclinical CRO Market Size by Type (2017-2022)
- 7.2.2 Europe Preclinical CRO Market Size by Type (2023-2028)
- 7.2.3 Europe Preclinical CRO Market Share by Type (2017-2028)
7.3 Europe Preclinical CRO Market Size by Application
- 7.3.1 Europe Preclinical CRO Market Size by Application (2017-2022)
- 7.3.2 Europe Preclinical CRO Market Size by Application (2023-2028)
- 7.3.3 Europe Preclinical CRO Market Share by Application (2017-2028)
7.4 Europe Preclinical CRO Market Size by Country
- 7.4.1 Europe Preclinical CRO Market Size by Country (2017-2022)
- 7.4.2 Europe Preclinical CRO Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Preclinical CRO Market Size (2017-2028)
8.2 Asia-Pacific Preclinical CRO Market Size by Type
- 8.2.1 Asia-Pacific Preclinical CRO Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Preclinical CRO Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Preclinical CRO Market Share by Type (2017-2028)
8.3 Asia-Pacific Preclinical CRO Market Size by Application
- 8.3.1 Asia-Pacific Preclinical CRO Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Preclinical CRO Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Preclinical CRO Market Share by Application (2017-2028)
8.4 Asia-Pacific Preclinical CRO Market Size by Region
- 8.4.1 Asia-Pacific Preclinical CRO Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Preclinical CRO Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia

9 Latin America

9.1 Latin America Preclinical CRO Market Size (2017-2028)
9.2 Latin America Preclinical CRO Market Size by Type
- 9.2.1 Latin America Preclinical CRO Market Size by Type (2017-2022)
- 9.2.2 Latin America Preclinical CRO Market Size by Type (2023-2028)
- 9.2.3 Latin America Preclinical CRO Market Share by Type (2017-2028)
9.3 Latin America Preclinical CRO Market Size by Application
- 9.3.1 Latin America Preclinical CRO Market Size by Application (2017-2022)
- 9.3.2 Latin America Preclinical CRO Market Size by Application (2023-2028)
- 9.3.3 Latin America Preclinical CRO Market Share by Application (2017-2028)
9.4 Latin America Preclinical CRO Market Size by Country
- 9.4.1 Latin America Preclinical CRO Market Size by Country (2017-2022)
- 9.4.2 Latin America Preclinical CRO Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Preclinical CRO Market Size (2017-2028)
10.2 Middle East & Africa Preclinical CRO Market Size by Type
- 10.2.1 Middle East & Africa Preclinical CRO Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Preclinical CRO Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Preclinical CRO Market Share by Type (2017-2028)
10.3 Middle East & Africa Preclinical CRO Market Size by Application
- 10.3.1 Middle East & Africa Preclinical CRO Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Preclinical CRO Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Preclinical CRO Market Share by Application (2017-2028)
10.4 Middle East & Africa Preclinical CRO Market Size by Country
- 10.4.1 Middle East & Africa Preclinical CRO Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Preclinical CRO Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE

11 Key Players Profiles

11.1 Charles River
- 11.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.1.2 Preclinical CRO Product Overview
- 11.1.3 Charles River Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.1.4 Main Business/Business Overview
11.2 Wuxi AppTec
- 11.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.2.2 Preclinical CRO Product Overview
- 11.2.3 Wuxi AppTec Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.2.4 Main Business/Business Overview
11.3 Labcorp
- 11.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.3.2 Preclinical CRO Product Overview
- 11.3.3 Labcorp Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.3.4 Main Business/Business Overview
11.4 Eurofins Scientific
- 11.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.4.2 Preclinical CRO Product Overview
- 11.4.3 Eurofins Scientific Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.4.4 Main Business/Business Overview
11.5 PPD, Inc.
- 11.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.5.2 Preclinical CRO Product Overview
- 11.5.3 PPD, Inc. Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.5.4 Main Business/Business Overview
11.6 ICON Plc.
- 11.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.6.2 Preclinical CRO Product Overview
- 11.6.3 ICON Plc. Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.6.4 Main Business/Business Overview
11.7 Pharmaron
- 11.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.7.2 Preclinical CRO Product Overview
- 11.7.3 Pharmaron Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.7.4 Main Business/Business Overview
11.8 Inotiv
- 11.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.8.2 Preclinical CRO Product Overview
- 11.8.3 Inotiv Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.8.4 Main Business/Business Overview
11.9 ChemPartner
- 11.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.9.2 Preclinical CRO Product Overview
- 11.9.3 ChemPartner Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.9.4 Main Business/Business Overview
11.10 JOINN Lab
- 11.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.10.2 Preclinical CRO Product Overview
- 11.10.3 JOINN Lab Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.10.4 Main Business/Business Overview
11.11 EVOTEC
- 11.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.11.2 Preclinical CRO Product Overview
- 11.11.3 EVOTEC Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.11.4 Main Business/Business Overview
11.12 Medicilon
- 11.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.12.2 Preclinical CRO Product Overview
- 11.12.3 Medicilon Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.12.4 Main Business/Business Overview
11.13 Crown Bioscience
- 11.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.13.2 Preclinical CRO Product Overview
- 11.13.3 Crown Bioscience Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.13.4 Main Business/Business Overview
11.14 Champion Oncology
- 11.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.14.2 Preclinical CRO Product Overview
- 11.14.3 Champion Oncology Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.14.4 Main Business/Business Overview

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Preclinical CRO Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Global Preclinical CRO Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 3. Global Preclinical CRO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 4. Global Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
Table 5. Global Preclinical CRO Market Share by Region (2017-2022)
Table 6. Global Preclinical CRO Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 7. Global Preclinical CRO Market Share by Region (2023-2028)
Table 8. Preclinical CRO Market Trends
Table 9. Preclinical CRO Market Drivers
Table 10. Preclinical CRO Market Challenges
Table 11. Global Preclinical CRO Revenue by Players (2019-2022) & (US$ Million)
Table 12. Global Preclinical CRO Market Share by Players (2019-2022)
Table 13. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2021)
Table 14. Ranking of Global Top Preclinical CRO Companies by Revenue (US$ Million) in 2021
Table 15. Global 5 Largest Players Market Share by Preclinical CRO Revenue (CR5) & (2019-2022)
Table 16. Key Players Headquarters and Area Served
Table 17. Established Date of Preclinical CRO Players
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Preclinical CRO Revenue Market Share by Type (2017-2022)
Table 21. Global Preclinical CRO Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Preclinical CRO Revenue Market Share by Type (2023-2028)
Table 23. Global Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Preclinical CRO Revenue Market Share by Application (2017-2022)
Table 25. Global Preclinical CRO Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Preclinical CRO Revenue Market Share by Application (2023-2028)
Table 27. North America Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 28. North America Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 29. North America Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 30. North America Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 31. North America Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 34. Europe Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 35. Europe Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 36. Europe Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 37. Europe Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 41. Asia-Pacific Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 42. Asia-Pacific Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 43. Asia-Pacific Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
Table 44. Asia-Pacific Preclinical CRO Market Size by Region (2023-2028) & (US$ Million)
Table 45. Latin America Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 46. Latin America Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 47. Latin America Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 48. Latin America Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 49. Latin America Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 50. Latin America Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 51. Middle East & Africa Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 52. Middle East & Africa Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 53. Middle East & Africa Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 54. Middle East & Africa Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 55. Middle East & Africa Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 56. Middle East & Africa Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 57. Charles River Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 58. Charles River Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 59. Wuxi AppTec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 60. Wuxi AppTec Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 61. Labcorp Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 62. Labcorp Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 63. Eurofins Scientific Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 64. Eurofins Scientific Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 65. PPD, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 66. PPD, Inc. Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 67. ICON Plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 68. ICON Plc. Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 69. Pharmaron Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 70. Pharmaron Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 71. Inotiv Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 72. Inotiv Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 73. ChemPartner Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 74. ChemPartner Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 75. JOINN Lab Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 76. JOINN Lab Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 77. EVOTEC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 78. EVOTEC Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 79. Medicilon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 80. Medicilon Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 81. Crown Bioscience Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 82. Crown Bioscience Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 83. Champion Oncology Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 84. Champion Oncology Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Preclinical CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Figure 2. Global Preclinical CRO Market Share by Type: 2021 VS 2028
Figure 3. Bioanalysis and DMPK Studies Features
Figure 4. Toxicology Testing Features
Figure 5. Safety Pharmacology Features
Figure 6. Other Features
Figure 7. Global Preclinical CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Figure 8. Global Preclinical CRO Market Share by Application: 2021 VS 2028
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Medical Device Companies Case Studies
Figure 11. Others Case Studies
Figure 12. Preclinical CRO Report Years Considered
Figure 13. Global Preclinical CRO Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Preclinical CRO Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Preclinical CRO Market Share by Region: 2021 VS 2028
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Preclinical CRO Market Share by Players in 2021
Figure 18. Global Top Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical CRO as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Preclinical CRO Revenue in 2021
Figure 20. North America Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Preclinical CRO Market Share by Type (2017-2028)
Figure 22. North America Preclinical CRO Market Share by Application (2017-2028)
Figure 23. North America Preclinical CRO Market Share by Country (2017-2028)
Figure 24. United States Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Preclinical CRO Market Share by Type (2017-2028)
Figure 28. Europe Preclinical CRO Market Share by Application (2017-2028)
Figure 29. Europe Preclinical CRO Market Share by Country (2017-2028)
Figure 30. Germany Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Preclinical CRO Market Share by Type (2017-2028)
Figure 37. Asia-Pacific Preclinical CRO Market Share by Application (2017-2028)
Figure 38. Asia-Pacific Preclinical CRO Market Share by Region (2017-2028)
Figure 39. China Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Preclinical CRO Market Share by Type (2017-2028)
Figure 47. Latin America Preclinical CRO Market Share by Application (2017-2028)
Figure 48. Latin America Preclinical CRO Market Share by Country (2017-2028)
Figure 49. Mexico Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Preclinical CRO Market Share by Type (2017-2028)
Figure 53. Middle East & Africa Preclinical CRO Market Share by Application (2017-2028)
Figure 54. Middle East & Africa Preclinical CRO Market Share by Country (2017-2028)
Figure 55. Turkey Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Preclinical CRO Product Picture Examples of Charles River
Figure 59. C'淩'滵MO Product Picture Examples of Wuxi AppTec
Figure 60. Preclinical CRO Product Picture Examples of Eurofins Scientific
Figure 61. Preclinical CRO Pharmacology and Toxicology Assessment Product Picture Examples of Inotiv
Figure 62. Preclinical CRO Product Picture Examples of ChemPartner
Figure 63. Preclinical CRO Product Picture Examples of Medicilon
Figure 64. Preclinical CRO Product Picture Examples of Crown Bioscience
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed